Cerebrospinal fluid apo E and apo A-I concentrations in early- and late- onset Alzheimer's disease

Neuroscience Letters

Volumn 231, Issue 3, 1997, Pages 175-178

  Song, Hua ^a   Saito, Kuniaki ^a   Seishima, Mitsuru ^a   Noma, Akio ^a   Urakami, Katsuya ^b   Nakashima, Kenji ^b  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Apolipoprotein A I; Apolipoprotein E; Cerebrospinal fluid; Neurodegenerative disorders

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; LIPOPROTEIN METABOLISM; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; ONSET AGE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0030763288     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00558-2     Document Type: Article

References (40)

1. Arai, H., Terajima, M., Miura, M., Higuchi, S., Muramatsu, T., Machida, N., Seiki, H., Takase, S., Clark, C.M., Lee, V.M.-Y., Trojanowski, J.Q. and Sasaki, H., Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease, Ann. Neurol., 38 (1995) 649-653.
2. Blennow, K., Hesse, C. and Fredman, P., Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease, NeuroReport, 5 (1994) 2534-2536.
3. Boerwinkle, E. and Utermann, G., Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism, Am. J. Hum. Genet., 42 (1988) 104-112.
4. Boyles, J.K., Zoellner, C.D., Anderson, L.J., Kosik, L.M., Pita, R.E., Weisgraber, K.H., Hui, D.Y., Mahley, R.W., Gebicke-Haerter, P.J., Ignatius, M.J. and Shooter, E.M., A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve, J. Clin. Invest., 83 (1989) 1015-1031.
5. Cassel, C.K. and Walsh, J.R. (Eds.), Geriatric Medicine, Vol. I, Medical, Psychiatric and Pharmacological Topics, Springer-Verlag, New York, 1988, pp. 43-49.
6. Christie, R.H., Chung, H., Rebeck, W., Strickland, D. and Hyman, B.T., Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease, J. Neuropathol. Exp. Neurol., 55 (1996) 491-498.
7. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
8. Diedrich, J.F., Minnigan, H., Carp, R.I., Whitaker, J.N., Race, R., Frey, W. and Hasse, A.T., Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes, J. Virol., 65 (1991) 4759-4768.
9. Eto, M., Watanabe, K. and Ishii, K., A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations, Clin. Genet., 30 (1986) 422-427.
10. Harr, S.D., Unit, L., Hollister, R., Hyman, B.T. and Mendez, A.J., Brain expression of apolipoprotein E, J, and A-I in Alzheimer's disease, J. Neurochem., 66 (1996) 2429-2435.
11. Lee, V.M.-Y., Balin, B.J., Otvos, L. Jr. and Trojanowski, J.Q., A68: a major subunit of paired helical filaments and derivatized forms of normal tau, Science, 251 (1991) 675-678.
12. Lehtimäki, T., Pirttilä, T., Mehta, P.D., Wisniewski, H.M., Frey, H. and Nikkari, T., Apolipoprotein E (apo E) polymorphism and its influence on apo E concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease, Hum. Genet., 95 (1995) 39-42.
13. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. and Beyreuther, K., Amyloid plaque core protein in Alzheimer's disease and Down syndrome, Proc. Natl. Acad. Sci. USA, 82 (1985) 4245-4249.
14. Matsubara, E., Hirai, S., Amari, M., Shoji, M., Yamaguchi, H., Okamoto, K., Ishiguro, K., Harigaya, Y. and Wakabayashi, K., α1-Antichimotrypsin as a possible biochemical marker for Alzheimer's type dementia, Ann. Neurol., 28 (1990) 561-567.
15. Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T.K., Tang, M.X. and Maestre, G., The apolipoprotein ∈4 alle in patients with Alzheimer's disease, Ann. Neurol., 34 (1993) 752-754.
16. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group, Neurology, 34 (1984) 939-944.
17. Merched, A., Blain, H., Visvikis, S., Herbecth, B., Jeandel, C. and Siest, G., Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease, J. Neurol. Sci., 145 (1997) 33-39.
18. Murakami, M., Ushio, Y., Morino, Y., Ohta, T. and Matsukado, Y., Immunohistochemical localization of apolipoprotein E in human glial neoplasmas, J. Clin. Invest., 82 (1988) 177-188.
19. Murrell, J., Farlow, M., Ghetti, B. and Benson, M.D., A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease, Science, 254 (1991) 97-99.
20. Nakamura, T., Shoji, M., Harigaya, Y., Watanabe, M., Hosoda, K., Cheung, T.T., Shaffer, L.M., Golde, T.E., Younkin, L.H., Younkin, S.G. and Hirai, S., Amyloid β protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease, Ann. Neurol., 36 (1994) 903-911.
21. Nalbantoglu, J., Gilfix, B.M., Bertrand, P., Robitaille, Y., Gauthier, S., Rosenblatt, D.S. and Poirier, J., Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies, Ann. Neurol., 36 (1994) 889-895.
22. Periak-Vance, M.A., Bebout, J.L., Gaskell, P.C. Jr., Yamaoka, L.H., Hung, W.-Y., Albers, M.J., Walker, A.P., Bartlett, R.J., Haynes, C.A., Welsh, K.A., Earl, N.L., Heyman, A., Clark, C.M. and Roses, A.D., Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage, Am. J. Hum. Genet., 48 (1991) 1034-1050.
23. Pirttilä, T., Mehta, P.D., Lehtimäki, T., Kim, K.S., Sersen, E.A., Frey, H., Nikkari, T. and Wisniewski, H.M., Relationship between apolipoprotein E4 allele and CSF amyloid β-protein in Alzheimer's disease and controls, Neurosci. Res. Commun., 15 (1994) 201-207.
24. Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D. and Weisgraber, K.H., Lipoproteins and their receptors in the central nervous system: characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E (LDL) receptors in the brain, J. Biol. Chem., 262 (1987) 14352-14360.
25. Poiirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P. and Gauthier, S., Apolipoprotein E polymorphism and Alzheimer's disease, Lancet, 342 (1993) 697-699.
26. Rebeck, G.W., Reiter, J.S., Strickland, D.K. and Hyman, B.T., Apolipoprotein E in sporadic Alzheimer's disease: alleic variation and receptor interactions, Neuron, 11 (1993) 575-580.
27. Roheim, P.S., Carey, M., Forte, T. and Cohen, A.S., Apolipoproteins in human cerebrospinal fluid, Proc. Natl. Acad. Sci. USA, 76 (1979) 4646-4649.
28. Rosler, N., Wichart, I. and Jellinger, K.A., Intra vitam lumber cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry, 60 (1996) 452-454.
29. Rumble, B., Retallack, R., Hilbich, M., Simms, G., Multhaup, G., Martins, R., Hockey, A., Montgomery, P., Beyreuther, K. and Masters, C.L., Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease, N. Engl. J. Med., 320 (1989) 1446-1452.
30. Saito, K., Seishima, M., Heyes, M.P., Song, H., Fujigaki, S., Maeda, S., Vickers, J.H. and Noma, A., Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury, Biochem. J., 32 (1997) 145-149.
31. Saunders, A.M., Strittmatter, W.J. and Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Albers, M.J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A.D., Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43 (1993) 1467-1472.
32. Spitzer, R.L., Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., Revised, American Psychiatric Association, Washington DC, 1987.
33. St. George-Hyslop, P.H., Tanzi, R.E., Polinsky, R.J., Haines, J.L., Nee, L., Watkins, P.C., Myers, R.H., Feldman, R.G., Pollen, D., Drachman, D., Growdon, J., Bruni, A., Foncin, J.-F., Salmon, D., Frommelt, P., Amaducci, L., Sorbi, S., Piacentini, S., Stewart, G.D., Hobbs, W.J., Conneally, P.M. and Gusella, J.F., The genetic defect causing familial Alzheimer's disease maps on chromosome 21, Science, 235 (1987) 885-890.
34. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D., Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Natl. USA, 90 (1993) 1977-1981.
35. Stoll, G., Mueller, H.W., Trapp, B.D. and Griffin, J.W., Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve, Glia, 2 (1989) 170-176.
36. Terry, R.D. and Davies, P., Dementia of the Alzheimer's type, Annu. Rev. Neurosci., 3 (1980) 77-95.
37. Urakami, K., Sato, K., Okada, A., Mura, T., Shimomura, T., Takenaka, T., Wakutani, Y., Oshima, T., Adachi, Y., Takahashi, K. and Endo, H., Cu, Zn superoxide dismutase in patients with dementia of the Alzheimer type, Acta Neurol. Scand., 91 (1995) 165-168.
38. van Duijn, C.M., de Knijff, P., Cruts, M., Wehnert, A., Havekes, L.M., Hofman, A. and Van Broeckhoven, C., Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease, Nature Genet., 7 (1994) 74-78.
39. Weisgraber, K.H., Roses, A.D. and Strittmatter, W.J., The role of apolipoprotein in the nervous system, Curr. Opin. Lipidol., 5 (1994) 110-116.
40. Wisniewski, T. and Frangioni, B., Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosci. Lett., 135 (1992) 235-238.